Combination drugs: Innovation in pharmacotherapy

P and T

Volumn 27, Issue 1, 2002, Pages 44-49

  Wertheimer, Albert I ^a   Morrison, Alan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIVIRUS AGENT; BENAZEPRIL; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; CARBIDOPA PLUS LEVODOPA; CARDIOVASCULAR AGENT; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; GLIBENCLAMIDE PLUS METFORMIN; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMIVUDINE; LOPINAVIR; MEDROXYPROGESTERONE ACETATE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; RITONAVIR; UNINDEXED DRUG; ZIDOVUDINE;

ARTHRITIS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DRUG FORMULATION; DRUG MIXTURE; FOOD AND DRUG ADMINISTRATION; HORMONE DEFICIENCY; HUMAN; HYPERTENSION; INFECTION; PARKINSON DISEASE; RESPIRATORY TRACT DISEASE; REVIEW;

EID: 0036153942     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Too many drugs? The clinical and economic value of incremental innovations
2. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension
3. The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistant to enalapril monotherapy
4. Efficacy and acceptability of the fixed low-dose perindopril-indapamide combination as first-line therapy in hypertension
5. Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension
6. A comparative review of new antipsychotics
7. A critical review of the "determinants" of patient compliance with therapeutic regimens
8. Attaining higher goals in HIV treatment: The central importance of adherence
9. The danger of fixed drug combinations
10. Fixed combinations of antimicrobial agents
11. Fixed-dose combinations of drugs
12. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
13. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Sub-Committee
14. Old antihypertensive agents-diuretics and beta-blockers: Do we know how and in whom they lower blood pressure?
15. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis
16. Treatment of hypertension in the elderly
17. Medical Research Council trial of treatment of hypertension in older adults: Principal results
18. Antihypertensive efficacy and side effects of three betablockers and a diuretic in elderly hypertensives: A report from the STOP-Hypertension study
19. Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly
20. Rationale for the use of a fixed combination in the treatment of hypertension
21. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
22. Therapeutic approaches to achieve desired blood pressure goals: Focus on calcium channel blockers
23. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
24. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
25. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma
26. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma
27. Inhaled salmeterol and fluticasone: A study comparing monotherapy and combination therapy in asthma
28. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: A randomized, double-blind, placebo-controlled, parallel-group study
29. Treatment of patients with essential hypertension: Amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo
30. Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension
31. Effects of verapamil and trandolapril in the treatment of hypertension
32. Lisinopril-hydrochlorothiazide combination vs lisinopril for the treatment of hypertension
33. Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension
34. Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction
35. Cost of cerivastatin in cost-effectiveness study
36. A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia
37. Cost containment for treating hypertension in African Americans: Impact of a combined ACE-inhibitor/calcium channel blocker